Rang	Name	Position
1	Dr. Najat Khan Ph.D.	CEO, President & Director
2	Mr. Ben R. Taylor	CFO & President of Recursion UK
3	Mr. Benjamin Mabey M.S.	Chief Technology Officer
4	Dr. David Hallett Ph.D.	Chief Scientific Officer
5	Mr. Nathan Hatfield J.D., M.B.A.	Chief Legal Officer & Corporate Secretary
6	Mr. Ryan Kelly	Chief Communications Officer
7	Ms. Erica Fox	Chief People and Impact Officer
8	Mr. Matthew Kinn M.B.A.	Chief Business Officer
9	Mr. Sid Jain	Senior Vice President of Clinical Development & Data Science
10	Dr. Vicki L. Goodman M.D.	Chief Medical Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	9,38%	0,24 Mrd. USD
2	ARK Investment Management LLC	7,71%	0,20 Mrd. USD
3	State Street Corp	6,47%	0,17 Mrd. USD
4	Vanguard Portfolio Management, LLC	5,81%	0,15 Mrd. USD
5	Baillie Gifford & Co Limited.	4,38%	0,11 Mrd. USD
6	Vanguard Capital Management, LLC	4,25%	0,11 Mrd. USD
7	Geode Capital Management, LLC	2,58%	0,07 Mrd. USD
8	SoftBank Group Corp	2,54%	0,07 Mrd. USD
9	MIC Capital Management UK LLP	1,80%	0,05 Mrd. USD
10	UBS Group AG	1,67%	0,04 Mrd. USD
11	NORGES BANK	1,27%	0,03 Mrd. USD
12	Data Collective IV GP, LLC	1,11%	0,03 Mrd. USD
13	Amova Asset Management Americas, Inc	1,03%	0,03 Mrd. USD
14	Sumitomo Mitsui Trust Group Inc	1,03%	0,03 Mrd. USD
15	Northern Trust Corp	0,89%	0,02 Mrd. USD
16	Marshall Wace Asset Management Ltd	0,88%	0,02 Mrd. USD
17	Charles Schwab Investment Management Inc	0,77%	0,02 Mrd. USD
18	DCVC Opportunity Fund II GP, LLC	0,74%	0,02 Mrd. USD
19	The Goldman Sachs Group Inc	0,73%	0,02 Mrd. USD
20	Vanguard Fiduciary Trust Co	0,65%	0,02 Mrd. USD